Insights

UK brand owners prejudiced at EUIPO by combination of COVID-19 and Brexit

by Roland Mallinson

The General Court looks at distinctiveness of the XOXO mark

UK increases scrutiny of tech and life sciences deals

Mergers and acquisitions in the tech and life sciences sectors may be subject to closer scrutiny by the UK competition authority and by the UK government in future.

by Paolo Palmigiano

6 of 6 Insights

easyJet opposes Easy Nurse at the UKIPO

by Elena Glengarry

Global Data Hub – HR data: an update

by multiple authors

Security over IP

Considerations when taking security over IP.

by Louise Popple

7 of 7 Insights

Financial services update - July 2020

by Daniel Hirschfield

Superman knocks out Superzings in EUIPO opposition

Brexit and MDR readiness for overseas medical devices manufacturers: where should you locate your sales operations in Europe?

by Alison Dennis

EU law on the "technical result" and "substantial value" exclusions for shape marks

by Timothy Pinto

Arbitration for life sciences companies

by Tasmina Goraya, PhD